Company profile: Probiodrug
1.1 - Company Overview
Company description
- Provider of drug discovery and development focused on molecules for the treatment of neuronal and autoimmune diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Probiodrug
Premier Biotech
HQ: United States
Website
- Description: Provider of drug testing diagnostic devices and laboratory services, including drugs of abuse testing delivering accurate results in under 10 minutes with observed collection to prevent adulteration. Offers the OT-Scan app for capturing and reporting drug screen results with automated test interpretation, secure data transmission, and in-app confirmation testing ordering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Premier Biotech company profile →
Intelect Medical
HQ: United States
Website
- Description: Provider of implantable neuromodulation systems and deep brain stimulation (DBS) therapies and technology for recovery from stroke and traumatic brain injury.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelect Medical company profile →
AZ Therapies
HQ: United States
Website
- Description: Provider of clinical-stage biotech R&D aimed at breakthrough treatments for neuroinflammation-related diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AZ Therapies company profile →
Newron Pharmaceuticals
HQ: Italy
Website
- Description: Provider of biopharmaceutical therapies for central and peripheral nervous system diseases, including Xadago (safinamide), an approved treatment for Parkinson’s disease available in the EU, Switzerland, the U.S., Canada, Australia, New Zealand, and Israel; and investigational candidates Evenamide as a potential first add-on therapy for positive symptoms of schizophrenia, and Ralfinamide for specific rare pain indications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newron Pharmaceuticals company profile →
Oligomerix
HQ: United States
Website
- Description: Provider of target identification and validation technologies to enhance drug discovery for neurodegenerative diseases, and tau-targeting therapeutics including OLX-07010, a Phase 1 small molecule inhibitor of tau self-association, a series of tau small molecule inhibitors, and companion biomarker programs to aid diagnosis and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oligomerix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Probiodrug
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Probiodrug
2.2 - Growth funds investing in similar companies to Probiodrug
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Probiodrug
4.2 - Public trading comparable groups for Probiodrug
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →